Mistletoe
Mistletoe as it relates to DILI in Health report: Genetics of Antibiotics-Induced Liver Injury
Mistletoe and Drug-Induced Liver Injury (DILI)
Mistletoe is a plant that has been used in traditional medicine for various purposes, including as a complementary therapy for cancer. However, there have been reports of mistletoe causing drug-induced liver injury (DILI) in some individuals.
Studies have shown that mistletoe extracts can have hepatotoxic effects, leading to liver damage in certain cases. The exact mechanisms by which mistletoe causes liver injury are not fully understood, but it is believed to involve oxidative stress, inflammation, and immune-mediated responses.
Patients who are using mistletoe as a complementary therapy should be monitored closely for signs of liver injury, such as jaundice, abdominal pain, and elevated liver enzymes. It is important for healthcare providers to be aware of the potential hepatotoxic effects of mistletoe and to consider this when evaluating patients with unexplained liver injury.
In conclusion, while mistletoe may have some potential health benefits, it is important to be cautious about its use, especially in individuals with pre-existing liver conditions or those taking medications that may interact with mistletoe and increase the risk of DILI.
Supplements for DILI
Here are some dietary supplements related to the content in this report. Click the shopping cart to purchase the supplement from our partners.
-
Green tea extract
Contains catechins which may increase oxidative stress and liver cell damage when combined with hepatotoxic antibiotics.
-
Greater celandine
Alkaloids like chelidonine may further impair liver function when the organ is under stress from antibiotics.
-
Chaparral
Nordamnacanthal is a quinone that could synergistically increase antibiotic liver toxicity through mitochondrial dysfunction.
-
Germander
Diterpenoids may amplify antibiotic liver injury by disrupting bile salt export and causing cholestasis.
-
Mistletoe
Contains toxic lectins which could worsen immunological reactions or alter detox pathways of antibiotic metabolites.
-
Skullcap
Flavonoids may inhibit pathways involved in hepatic metabolism and clearance of antibiotics from the liver.
-
Valerian
Isovaltrate and other constituents thought to directly damage cell membranes, potentially worsening antibiotic hepatocellular toxicity.
-
Kava kava
Kavalactones like desmethoxyyangonin may inhibit CYP450 liver enzymes important for antibiotic clearance.
-
St. John's wort
Hyperforin alters PXR nuclear receptors and could decrease bile acid transport, contributing to antibiotic cholestasis.
-
Ginseng
Ginsenosides may inhibit P-glycoprotein transporters important for antibiotic efflux from hepatocytes, allowing accumulation of toxic levels.
-
Aloe vera
Anthraquinone glycosides possibly damage cell membranes and worsen antibiotic-mediated liver cell necrosis.
-
Ashwagandha
Withanolides thought to cause oxidative stress which synergizes with redox-cycling antibiotic metabolites.
-
Andrographis
Diterpene lactones may reduce bile acid secretion and flow, contributing to cholestatic injury.
-
Noni juice
Anthraquinones could impair mitochondrial function and increase antibiotic hepatotoxicity.
-
Peppermint oil
Menthol interferes with CYP450s and UGTs involved in antibiotic metabolism and clearance.
-
Kratom
Mitragynine and 7-hydroxymitragynine are metabolized in liver and could enhance antibiotic toxicity.
-
Ephedra
Ephedrine alkaloids may deplete glutathione and reduce the liver's defense against antibiotic oxidative damage.
Disclaimer